Cargando…
A novel approach for fibrous dysplasia assessment using combined planar and quantitative SPECT/CT analysis of Tc-99m-diphosphonate bone scan in correlation with biological bone turnover markers of disease activity
PURPOSE: To investigate the emerging role of Tc-99m-labeled diphosphonate (Tc-99m-DPD) uptake quantification by SPECT/CT in fibrous dysplasia (FD) bone lesions and its correlation with biological bone turnover markers (BTMs) of disease activity. MATERIALS AND METHODS: Seven patients (49 ± 16 years)...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732018/ https://www.ncbi.nlm.nih.gov/pubmed/36507503 http://dx.doi.org/10.3389/fmed.2022.1050854 |
_version_ | 1784846034526011392 |
---|---|
author | Jreige, Mario Hall, Nicolas Becce, Fabio Aubry-Rozier, Bérengère Gonzalez Rodriguez, Elena Schaefer, Niklaus Prior, John O. Nicod Lalonde, Marie |
author_facet | Jreige, Mario Hall, Nicolas Becce, Fabio Aubry-Rozier, Bérengère Gonzalez Rodriguez, Elena Schaefer, Niklaus Prior, John O. Nicod Lalonde, Marie |
author_sort | Jreige, Mario |
collection | PubMed |
description | PURPOSE: To investigate the emerging role of Tc-99m-labeled diphosphonate (Tc-99m-DPD) uptake quantification by SPECT/CT in fibrous dysplasia (FD) bone lesions and its correlation with biological bone turnover markers (BTMs) of disease activity. MATERIALS AND METHODS: Seven patients (49 ± 16 years) with a confirmed diagnosis of FD were included in this retrospective study. Bone scans with Tc-99m-DPD and quantitative SPECT/CT (xSPECT/CT) were performed. SUV(max) (maximum standard unit value) and SUV(mean) (mean standard unit value) were measured in all FD bone lesions. The skeletal burden score (SBS) was assessed on planar scintigraphy and multiplied by mean SUV(max) and SUV(mean) to generate two new parameters, SBS_SUV(max) and SBS_SUV(mean), respectively. Planar and xSPECT/CT quantitative measures were correlated with biological BTMs of disease activity, including fibroblast growth factor 23 (FGF-23), alkaline phosphatase (ALP), procollagen 1 intact N-terminal propeptide (P1NP) and C-terminal telopeptide (CTX), as well as scoliosis angle measured on radiographs. Statistical significance was evaluated with Spearman’s correlations. RESULTS: A total of 76 FD bone lesions were analyzed, showing an average SUV(max) and SUV(mean) (g/mL) of 13 ± 7.3 and 8 ± 4.5, respectively. SBS, SBS_SUV(max) and SBS_SUV(mean) values were 30.8 ± 25.6, 358 ± 267 and 220.1 ± 164.5, respectively. Mean measured values of FGF-23 (pg/mL), ALP (U/L), P1NP (μg/L) and CTX (pg/mL) were 98.4 (22–175), 283.5 (46–735), 283.1 (31–1,161) and 494 (360–609), respectively. Mean scoliosis angle was 15.7 (7–22) degrees. We found a very strong positive correlation between planar-derived SBS and CTX (r = 0.96, p = 0.010), but no significant correlation between SUV(max) or SUV(mean) and biological BTMs. SBS_SUV(max) showed a strong to very strong positive correlation with CTX (ρ = 0.99, p = 0.002), FGF-23 (ρ = 0.91, p = 0.010), ALP (ρ = 0.82, p = 0.020), and P1NP (ρ = 0.78, p = 0.039), respectively. CONCLUSION: This study showed that biological BTMs are significantly correlated with diphosphonate uptake on bone scan, quantified by a new parameter combining information from both planar and quantitative SPECT/CT. Further analysis of bone scan quantitative SPECT/CT data in a larger patient population might help better characterize the skeletal disease burden in FD, and guide treatment and follow-up. |
format | Online Article Text |
id | pubmed-9732018 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97320182022-12-10 A novel approach for fibrous dysplasia assessment using combined planar and quantitative SPECT/CT analysis of Tc-99m-diphosphonate bone scan in correlation with biological bone turnover markers of disease activity Jreige, Mario Hall, Nicolas Becce, Fabio Aubry-Rozier, Bérengère Gonzalez Rodriguez, Elena Schaefer, Niklaus Prior, John O. Nicod Lalonde, Marie Front Med (Lausanne) Medicine PURPOSE: To investigate the emerging role of Tc-99m-labeled diphosphonate (Tc-99m-DPD) uptake quantification by SPECT/CT in fibrous dysplasia (FD) bone lesions and its correlation with biological bone turnover markers (BTMs) of disease activity. MATERIALS AND METHODS: Seven patients (49 ± 16 years) with a confirmed diagnosis of FD were included in this retrospective study. Bone scans with Tc-99m-DPD and quantitative SPECT/CT (xSPECT/CT) were performed. SUV(max) (maximum standard unit value) and SUV(mean) (mean standard unit value) were measured in all FD bone lesions. The skeletal burden score (SBS) was assessed on planar scintigraphy and multiplied by mean SUV(max) and SUV(mean) to generate two new parameters, SBS_SUV(max) and SBS_SUV(mean), respectively. Planar and xSPECT/CT quantitative measures were correlated with biological BTMs of disease activity, including fibroblast growth factor 23 (FGF-23), alkaline phosphatase (ALP), procollagen 1 intact N-terminal propeptide (P1NP) and C-terminal telopeptide (CTX), as well as scoliosis angle measured on radiographs. Statistical significance was evaluated with Spearman’s correlations. RESULTS: A total of 76 FD bone lesions were analyzed, showing an average SUV(max) and SUV(mean) (g/mL) of 13 ± 7.3 and 8 ± 4.5, respectively. SBS, SBS_SUV(max) and SBS_SUV(mean) values were 30.8 ± 25.6, 358 ± 267 and 220.1 ± 164.5, respectively. Mean measured values of FGF-23 (pg/mL), ALP (U/L), P1NP (μg/L) and CTX (pg/mL) were 98.4 (22–175), 283.5 (46–735), 283.1 (31–1,161) and 494 (360–609), respectively. Mean scoliosis angle was 15.7 (7–22) degrees. We found a very strong positive correlation between planar-derived SBS and CTX (r = 0.96, p = 0.010), but no significant correlation between SUV(max) or SUV(mean) and biological BTMs. SBS_SUV(max) showed a strong to very strong positive correlation with CTX (ρ = 0.99, p = 0.002), FGF-23 (ρ = 0.91, p = 0.010), ALP (ρ = 0.82, p = 0.020), and P1NP (ρ = 0.78, p = 0.039), respectively. CONCLUSION: This study showed that biological BTMs are significantly correlated with diphosphonate uptake on bone scan, quantified by a new parameter combining information from both planar and quantitative SPECT/CT. Further analysis of bone scan quantitative SPECT/CT data in a larger patient population might help better characterize the skeletal disease burden in FD, and guide treatment and follow-up. Frontiers Media S.A. 2022-11-25 /pmc/articles/PMC9732018/ /pubmed/36507503 http://dx.doi.org/10.3389/fmed.2022.1050854 Text en Copyright © 2022 Jreige, Hall, Becce, Aubry-Rozier, Gonzalez Rodriguez, Schaefer, Prior and Nicod Lalonde. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Jreige, Mario Hall, Nicolas Becce, Fabio Aubry-Rozier, Bérengère Gonzalez Rodriguez, Elena Schaefer, Niklaus Prior, John O. Nicod Lalonde, Marie A novel approach for fibrous dysplasia assessment using combined planar and quantitative SPECT/CT analysis of Tc-99m-diphosphonate bone scan in correlation with biological bone turnover markers of disease activity |
title | A novel approach for fibrous dysplasia assessment using combined planar and quantitative SPECT/CT analysis of Tc-99m-diphosphonate bone scan in correlation with biological bone turnover markers of disease activity |
title_full | A novel approach for fibrous dysplasia assessment using combined planar and quantitative SPECT/CT analysis of Tc-99m-diphosphonate bone scan in correlation with biological bone turnover markers of disease activity |
title_fullStr | A novel approach for fibrous dysplasia assessment using combined planar and quantitative SPECT/CT analysis of Tc-99m-diphosphonate bone scan in correlation with biological bone turnover markers of disease activity |
title_full_unstemmed | A novel approach for fibrous dysplasia assessment using combined planar and quantitative SPECT/CT analysis of Tc-99m-diphosphonate bone scan in correlation with biological bone turnover markers of disease activity |
title_short | A novel approach for fibrous dysplasia assessment using combined planar and quantitative SPECT/CT analysis of Tc-99m-diphosphonate bone scan in correlation with biological bone turnover markers of disease activity |
title_sort | novel approach for fibrous dysplasia assessment using combined planar and quantitative spect/ct analysis of tc-99m-diphosphonate bone scan in correlation with biological bone turnover markers of disease activity |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732018/ https://www.ncbi.nlm.nih.gov/pubmed/36507503 http://dx.doi.org/10.3389/fmed.2022.1050854 |
work_keys_str_mv | AT jreigemario anovelapproachforfibrousdysplasiaassessmentusingcombinedplanarandquantitativespectctanalysisoftc99mdiphosphonatebonescanincorrelationwithbiologicalboneturnovermarkersofdiseaseactivity AT hallnicolas anovelapproachforfibrousdysplasiaassessmentusingcombinedplanarandquantitativespectctanalysisoftc99mdiphosphonatebonescanincorrelationwithbiologicalboneturnovermarkersofdiseaseactivity AT beccefabio anovelapproachforfibrousdysplasiaassessmentusingcombinedplanarandquantitativespectctanalysisoftc99mdiphosphonatebonescanincorrelationwithbiologicalboneturnovermarkersofdiseaseactivity AT aubryrozierberengere anovelapproachforfibrousdysplasiaassessmentusingcombinedplanarandquantitativespectctanalysisoftc99mdiphosphonatebonescanincorrelationwithbiologicalboneturnovermarkersofdiseaseactivity AT gonzalezrodriguezelena anovelapproachforfibrousdysplasiaassessmentusingcombinedplanarandquantitativespectctanalysisoftc99mdiphosphonatebonescanincorrelationwithbiologicalboneturnovermarkersofdiseaseactivity AT schaeferniklaus anovelapproachforfibrousdysplasiaassessmentusingcombinedplanarandquantitativespectctanalysisoftc99mdiphosphonatebonescanincorrelationwithbiologicalboneturnovermarkersofdiseaseactivity AT priorjohno anovelapproachforfibrousdysplasiaassessmentusingcombinedplanarandquantitativespectctanalysisoftc99mdiphosphonatebonescanincorrelationwithbiologicalboneturnovermarkersofdiseaseactivity AT nicodlalondemarie anovelapproachforfibrousdysplasiaassessmentusingcombinedplanarandquantitativespectctanalysisoftc99mdiphosphonatebonescanincorrelationwithbiologicalboneturnovermarkersofdiseaseactivity AT jreigemario novelapproachforfibrousdysplasiaassessmentusingcombinedplanarandquantitativespectctanalysisoftc99mdiphosphonatebonescanincorrelationwithbiologicalboneturnovermarkersofdiseaseactivity AT hallnicolas novelapproachforfibrousdysplasiaassessmentusingcombinedplanarandquantitativespectctanalysisoftc99mdiphosphonatebonescanincorrelationwithbiologicalboneturnovermarkersofdiseaseactivity AT beccefabio novelapproachforfibrousdysplasiaassessmentusingcombinedplanarandquantitativespectctanalysisoftc99mdiphosphonatebonescanincorrelationwithbiologicalboneturnovermarkersofdiseaseactivity AT aubryrozierberengere novelapproachforfibrousdysplasiaassessmentusingcombinedplanarandquantitativespectctanalysisoftc99mdiphosphonatebonescanincorrelationwithbiologicalboneturnovermarkersofdiseaseactivity AT gonzalezrodriguezelena novelapproachforfibrousdysplasiaassessmentusingcombinedplanarandquantitativespectctanalysisoftc99mdiphosphonatebonescanincorrelationwithbiologicalboneturnovermarkersofdiseaseactivity AT schaeferniklaus novelapproachforfibrousdysplasiaassessmentusingcombinedplanarandquantitativespectctanalysisoftc99mdiphosphonatebonescanincorrelationwithbiologicalboneturnovermarkersofdiseaseactivity AT priorjohno novelapproachforfibrousdysplasiaassessmentusingcombinedplanarandquantitativespectctanalysisoftc99mdiphosphonatebonescanincorrelationwithbiologicalboneturnovermarkersofdiseaseactivity AT nicodlalondemarie novelapproachforfibrousdysplasiaassessmentusingcombinedplanarandquantitativespectctanalysisoftc99mdiphosphonatebonescanincorrelationwithbiologicalboneturnovermarkersofdiseaseactivity |